Towards Healthcare

Europe Pharmaceutical CDMO Companies, Corporate Milestones, Corporate Growth and Development Strategy, Mergers and Acquisitions (M&A), Market Trends Analysis

Date: January 2025

Europe Pharmaceutical CDMO Companies and Competitive Landscape

The Europe pharmaceutical CDMO market size is calculated at USD 35.48 billion in 2024, grew to USD 37.98 billion in 2025, and is projected to reach around USD 70.05 billion by 2034. The market is expanding at a CAGR of 7.04% between 2025 and 2034.

Top Companies in the Europe Pharmaceutical CDMO

Europe Pharmaceutical CDMO Market Companies

  • 3P Biopharmaceuticals
  • Adragos Pharma
  • AGC Biologics
  • Axplora
  • Biovian Oy
  • Boehringer Ingelheim
  • Delpharm
  • Fareva
  • FUJIFILM Diosynth Biotechnologies
  • Lonza Group AG
  • PCI Pharma Services
  • Recipharm AB
  • Richter Biologics

Europe Pharmaceutical CDMO Market Import Data - October 2024

IMPORTER NAME SUPPLIER NAME PRODUCT DESCRIPTION GROSS WEIGHT KG
TRADING HOUSE OF UKRAINIAN VETERINARY TECHNOLOGIES LLC UPS HEALTHCARE HUNGARY ZRT2040 BUDAORS AKRON UTCA 1 HUNGARY MEDICINAL PRODUCTS FOR VETERINARY USE ONLY CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC  268.08
LLC KONARK INTELMED EURO LIFECARE PRIVATE LIMITED OFF 509 510 5TH FLOOR B WING 215 ATRIUM CO OPERATIVE PREMISES MEDICINE FOR HUMANS 304.93
TOV ALSI LTDKYIV EDQM7 ALLEE KASTNER 67081 STRASBOURG FRANCE OFFICIAL EUROPEAN PHARMACOPOEIA STANDARD SAMPLES FOR LABORATORY TESTS DURING THE QUALITY CONTROL OF MEDICINAL PRODUCTS 0.3
TOV ALSI LTDKYIV WALTER FRIES TRADE AND TRANSPORTGLINDENBERGEN WEG 7A DE 39126 MAGDEBURG GERMANY LABORATORY REAGENTS IN THE FORM OF A MIXTURE THAT INCLUDES MORE THAN ONE COMPONENT USED FOR IN VITRO LABORATORY STUDIES 0.74
LLC REALAB B R VERNADSKOHO NORMAX LDARUA SANTA ISABEL 17 2430 475 MARINHA GRANDE PORTUGAL DIAGNOSTIC OR LABORATORY REAGENTS INDICATOR STRIP UNIVERSAL 1.98
LIMITED LIABILITY COMPANY KHIMLABORREAKTYV MERCK LIFE SCIENCE KGAAFRANKFURTER STRASSE 250 D 64271 DARMATADT GERMANY NON-MEDICAL DIAGNOSTIC REAGENTS FOR LABORATORY RESEARCH TOTAL HARDNESS  3.83